Lantheus Treats Big Money Well

And the maker of medical imaging tools could jump more due to market share gains related to new prostate cancer imaging products. But another likely reason is Big Money lifting the stock.

Big Money Loves Lantheus

So, what’s Big Money? Said simply, that’s when a stock goes up in price alongside chunky volumes. It’s indicative of institutions betting on the shares.

Smart money managers are always looking for the next hot stock. And Lantheus has many fundamental qualities that are attractive.

This sets up well for the stock going forward. But how the shares have been trading points to more upside. As I’ll show you, the Big Money has been consistent in the shares.

You see, fund managers are always looking to bet on the next outlier stocks…the best in class. They spend countless hours sizing up companies, reading reports, speaking to analysts…you name it. When they find a company firing on all cylinders, they pounce in a big way.

That’s why I’ve learned how critical it is to gauge Big Money demand for shares. To show you what I mean, have a look at all the Big Money signals LNTH has made the last year.

The last few weeks have seen Big Money activity too. Each green bar signals big trading volumes as the stock ramped in price:

Source: www.mapsignals.com

So far in 2022, the stock has attracted 18 Big Money buy signals. Generally speaking, recent green bars could mean more upside is ahead.

Now, let’s check out the technical action grabbing my attention:

• 1-month outperformance vs. Health Care Select Sector SPDR ETF (+16.3% vs. XLV)

Outperformance is important for leading stocks.

Lantheus Fundamental Analysis

Next, it’s a good idea to check under the hood. Meaning, I want to make sure the fundamental story is strong too. As you can see, Lantheus has been growing sales well and is expected to grow earnings in the future. Take a look:

• 1-year sales growth rate (+25.3%)
• 2-year vs. 1-year EPS growth estimate (+19.3%)

Source: FactSet

Marrying great fundamentals with technically superior stocks is a winning recipe over the long-term.

In fact, LNTH has become a top-rated stock at my research firm, MAPsignals. That means the stock has buy pressure, strong technicals, and growing fundamentals. We have a ranking process that showcases stocks like this on a weekly basis.

LNTH has a lot of qualities that are attracting Big Money. It’s made the Top 20 report twice this year, with its first appearance on 05/03/2022…and gaining 16.9% since. The blue bars below show when Lantheus was a top pick:

Source: www.mapsignals.com

It’s been a top stock in the health care sector according to the MAPsignals process. I wouldn’t be surprised if LNTH makes additional appearances in the years to come. Let’s tie this all together.

Lantheus Price Prediction

The Lantheus rally could have further to go. Big Money buying in the shares is signaling to take notice. Shares could be positioned for further upside. Given the historical gains in share price and strong fundamentals, this stock could be worth a spot in a diversified portfolio.

Disclosure: the author holds no positions in LNTH at the time of publication.

Learn more about the MAPsignals process here.

Contact

https://mapsignals.com/contact/